Psycho-education, pharmacotherapy, a monitoring plan, change-oriented interventions or admission to a clinic are treatment options on offer.
Most developed countries offer DNA testing for NDM patients to establish a personal molecular genetic diagnosis for family counselling and to plan personalized pharmacotherapy.
There are three phases in pharmacotherapy: acceptance of the treatment plan, execution of the drug regimen and discontinuation of dosing [ 27].
Person-time accumulated, as described previously, until the first of the following occurred: (1) patient switched to a different antipsychotic; (2) prescription filled for anti-diabetic pharmacotherapy; (3) disenrollment from health plan; (4) death; (5) end of study period.
* obligatory; $ for intervention patients only # Obtained from medical record § Obtained from medication record + Obtained from the patient during pharmaceutical anamnesis or questionnaire For the intervention patients the CRF also contains a separate part for documenting the pharmacotherapy review, the pharmaceutical care plan and monitoring and follow up evaluation of pharmacotherapy.
Hence there is still a need for large studies to evaluate the effectiveness of a so called patient centred pharmaceutical care process, including reviewing pharmacotherapy, formulating a pharmaceutical care plan and monitoring and follow up evaluating of pharmacotherapy, in daily practice of an integrated primary care setting.
The PHARM-study is one of the largest controlled trials to study the effect of the total pharmaceutical care process, including a pharmaceutical anamnesis, followed by a pharmacotherapy review, a pharmaceutical care plan, monitoring and follow up evaluation of pharmacotherapy, in an ordinary integrated primary care setting on medication related hospital admissions.
To ensure ample exposure for evaluation, individuals were followed from the 45th day after index date through the earliest of the following events: (1) prescription filled for anti-diabetic pharmacotherapy; (2) disenrollment from database/health plan; (3) death; (4) end of study period.
Third, we demonstrate the high level of engagement of Aboriginal participants with preventive care through chronic disease care planning and assenting to pharmacotherapy.
The steps of this pharmaceutical care process are a pharmaceutical anamnesis, a review of the patient's pharmacotherapy, the formulation and execution of a pharmaceutical care plan combined with the monitoring and follow up evaluation of the care plan and pharmacotherapy.
